Literature DB >> 12226013

Predicting survival of lung transplantation candidates with idiopathic interstitial pneumonia: does PaO(2) predict survival?

Suzanne J Timmer1, Amir M Karamzadeh, G L Yung, Jolene Kriett, Stewart W Jamieson, Cecilia M Smith.   

Abstract

OBJECTIVE: To find a parameter that would discriminate between the patients with idiopathic interstitial pneumonia who survived to undergo transplantation and those who died while waiting to undergo transplantation.
METHODS: A retrospective review was performed of all lung transplant referrals for idiopathic interstitial pneumonia that were listed with United Network for Organ Sharing at the University of California San Diego from January 1990 to February 1999. Of the 331 patients who were listed, 48 met the eligibility criteria. Patient demographics, radiographic studies, pathology reports, and the results of resting and exercise cardiopulmonary function tests were recorded from each patient's chart. Patients were divided into the following two groups: those patients who survived until transplantation and those still waiting were classified as "alive"; and those patients who died before undergoing transplantation were classified as "deceased."
RESULTS: Forty-three of 48 patients had a pathologic diagnosis. The cohort included 25 patients with usual interstitial pneumonitis, 3 patients with nonspecific interstitial pneumonitis, 1 patient with desquamative interstitial pneumonitis, and 14 patients with interstitial lung disease of unknown etiology. The only significant difference between the two groups was resting PaO(2) (p = 0.035). A stepwise multivariate analysis demonstrated that PaO(2) and FEV(1)/FVC ratio were significantly associated with survival (hazards ratio, 1.06; confidence interval, 0.99 to 1.13; p = 0.019).
CONCLUSIONS: A survival analysis using PaO(2) and FEV(1)/FVC ratio values proved to be statistically significant, but a prospective trial is needed to determine the clinical relevance of these parameters for predicting survival in patients with idiopathic interstitial pneumonia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226013     DOI: 10.1378/chest.122.3.779

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  David A Zisman; Arun S Karlamangla; David J Ross; Michael P Keane; John A Belperio; Rajan Saggar; Joseph P Lynch; Abbas Ardehali; Jonathan Goldin
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

Review 2.  Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature.

Authors:  Kristin D Kistler; Luba Nalysnyk; Philip Rotella; Dirk Esser
Journal:  BMC Pulm Med       Date:  2014-08-16       Impact factor: 3.317

3.  Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease.

Authors:  Kohei Ikezoe; Tomohiro Handa; Kiminobu Tanizawa; Toyofumi F Chen-Yoshikawa; Takeshi Kubo; Akihiro Aoyama; Hideki Motoyama; Kyoko Hijiya; Shinsaku Tokuda; Yoshinari Nakatsuka; Yuko Yamamoto; Ayako Oshima; Shin-Ichi Harashima; Sonoko Nagai; Toyohiro Hirai; Hiroshi Date; Kazuo Chin
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

Review 4.  Pulmonary fibrosis.

Authors:  David A Zisman; Michael P Keane; John A Belperio; Robert M Strieter; Joseph P Lynch
Journal:  Methods Mol Med       Date:  2005

5.  Pulmonary fibrosis: rate of disease progression as a trigger for referral for lung transplantation.

Authors:  Laura S Mackay; Rachel L Anderson; Gareth Parry; James Lordan; Paul A Corris; Andrew J Fisher
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.